SCHEMBL20876291

SCHEMBL20876291

CC(O)C1(c2ccccc2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.42
SLC6A2 P23975 2/20 0.42
SLC6A4 P31645 2/20 0.42
SLC6A3 Q01959 2/20 0.42
OPRM1 P35372 4/20 0.41
OPRL1 P41146 4/20 0.41
OPRK1 P41145 3/20 0.41
OPRD1 P41143 1/20 0.41
ALDH1A1 P00352 1/20 0.38
AKR1C1 Q04828 1/20 0.38
MMP1 P03956 1/20 0.37
MMP2 P08253 1/20 0.37
MMP9 P14780 1/20 0.37
GRIN2D O15399 1/20 0.37
GRIN3B O60391 1/20 0.37
GRIN1 Q05586 1/20 0.37
KCNH2 Q12809 1/20 0.37
GRIN2A Q12879 1/20 0.37
GRIN2B Q13224 1/20 0.37
GRIN2C Q14957 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8655542 0.90 SLC6A4 (0.54) SLC6A2SLC6A4SLC6A3AKR1C1HDAC4
SCHEMBL9790835 0.86 OPRM1 (0.52) CYP2D6SLC6A2SLC6A4SLC6A3OPRM1
SCHEMBL6485244 0.86 ALDH1A1 (0.40) CYP2D6SLC6A2SLC6A4SLC6A3OPRM1
SCHEMBL9378568 0.85 OPRM1 (0.49) CYP2D6SLC6A4OPRM1OPRL1OPRK1
SCHEMBL4576233 0.81 CYP2D6 (0.45) CYP2D6SLC6A2SLC6A4SLC6A3OPRM1
SCHEMBL25306257 0.81 HTR2A (0.38) CYP2D6SLC6A2SLC6A4SLC6A3OPRM1
SCHEMBL3380376 0.81 ALDH1A1 (0.38) CYP2D6SLC6A2SLC6A4SLC6A3OPRM1
SCHEMBL20558236 0.78 CYP19A1 (0.33) CYP2D6SLC6A4SLC6A3ALDH1A1
SCHEMBL7705762 0.78 SLC6A4 (0.55) SLC6A2SLC6A4SLC6A3OPRK1ALDH1A1
SCHEMBL19647190 0.77 SLC6A2 (0.51) CYP2D6SLC6A2SLC6A4SLC6A3OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3692019-B1 FUNGICIDAL PICOLINAMIDE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2022-11-16 EP disclosed
US-11395489-B2 Microbiocidal picolinamide derivatives SYNGENTA PARTICIPATIONS AG (CH) 2022-07-26 US disclosed
US-20200267977-A1 MICROBIOCIDAL PICOLINAMIDE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2020-08-27 US disclosed
EP-3692019-A1 MICROBIOCIDAL PICOLINAMIDE DERIVATIVES Syngenta Participations AG (CH) 2020-08-12 EP disclosed
CN-111183133-A Microbicidal picolinamide derivatives 先正达参股股份有限公司 2020-05-19 CN disclosed
WO-2019068812-A1 MICROBIOCIDAL PICOLINAMIDE DERIVATIVES SYNGENTA PARTICIPATIONS AG (CH) 2019-04-11 WO disclosed
US-20160126471-A1 ORGANIC OPTOELECTRIC DEVICE AND DISPLAY DEVICE SAMSUNG SDI CO., LTD. (KR) 2016-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11395489-B2 Microbiocidal picolinamide derivatives PRF1, CASP1, FPR1 CYP2D6 417/4885SLC6A2 3920/4885SLC6A4 3476/4885
US-20200267977-A1 MICROBIOCIDAL PICOLINAMIDE DERIVATIVES PRF1, CASP1, FPR1 CYP2D6 417/4885SLC6A2 3920/4885SLC6A4 3476/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.